Results 261 to 270 of about 3,900,516 (357)

CCL20/CXCL5 Drives Crosstalk Between Anaplastic Thyroid Cancer Stem Cells and Tumor‐Associated Macrophages to Promote Tumor Progression

Advanced Science, EarlyView.
This study elucidates the crosstalk between tumor‐associated macrophages (TAMs) and anaplastic thyroid cancer stem cells (ATCSCs). The findings reveal that CCL20 from THP‐1‐M2 activates the IRAK‐1/NF‐κB1/2 pathway in ATCSCs, thereby enhancing CXCL5 secretion.
Qi Liu, Yan Wang, Mingyuan Song, Jiapeng Huang, Jinyuan Shi, Wei Sun, Xiaoyu Ji, Yuang Chang, Bing Ma, Ping Zhang, Yuanyuan Yan, Hao Zhang   +11 more
wiley   +1 more source

Otolaryngology-Head and Neck Surgery Training and Service Delivery: An International Survey. [PDF]

Laryngoscope Investig Otolaryngol
Nuss S, Nakku D, Pandey A, Elwell Z, Fei-Zhang D, Srinivasan T, Patterson RH, Adeyemo A, Cherches A, Bangash AH, Mukuzi A, Seguya A, Kahinga AA, Petrucci B, Der Mussa C, Pietrobon C, Waterworth CJ, Daudu D, Shaye D, Smith E, Cahill G, Sprow H, Maina I, Fagan JJ, Wiedermann J, Xu MJ, Zalaquett N, Thapa NM, Hapunda R, Okerosi S, Tamir SO, Ibekwe T, Alkire B, Salano V, Din T, Global OHNS Initiative.   +35 more
europepmc   +1 more source

ANNUAL MEETING OF SOCIETY OF HEAD AND NECK SURGEONS

, 1968
NULL AUTHOR_ID
openalex   +1 more source

Second report on results of a randomised clinical trial of fast neutrons compared with chi or gamma rays in treatment of advanced tumours of head and neck. [PDF]

, 1977
M Catterall, D. K. Bewley, Ian Sutherland   +2 more
openalex   +1 more source

Lycium barbarum Glycopeptide Alleviates Neomycin‐Induced Ototoxicity by Inhibiting Tryptophan Hydroxylase‐Mediated Serotonin Biosynthesis

Advanced Science, EarlyView.
Lycium barbarum glycopeptide (LBGP), which is further extracted from Lycium barbarum polysaccharides, exhibits significant protective effects against neomycin‐induced hearing dysfunction including oxidative stress in cochlea and loss of key cells in cochlea.
Yunhao Wu, Li Zhang, Shengda Cao, Jingwen Zhang, Cheng Li, Yunlong Shan, Qiuping Liu, Zhexiong Yu, Qiaojun Fang, Yuhua Zhang, Xiaolong Fu, Kwok‐Fai So, Renjie Chai   +12 more
wiley   +1 more source

Predicting Early Death in Head and Neck Cancer-A Pilot Study. [PDF]

Cancers (Basel)
Talani C, Olsson H, Roberg K, Wiechec E, Almangush A, Mäkitie AA, Farnebo L.   +6 more
europepmc   +1 more source

Advances in Microfluidic Cochlea‐On‐A‐Chip

Advanced Science, EarlyView.
This review systematically examines diverse cell sources for inner ear organoids and outlines stepwise induction protocols. Furthermore, it discusses current applications and prospective developments of cochlea‐on‐a‐chip technologies in areas such as deafness modeling, mechanistic studies, and drug evaluation, with particular focus on gene‐therapy drug
Tian Shen, Shanying Han, Weiwei He, Wen Yang, Xinghua Tang, Xiaolong Zhao, Xinghong Liu, Zhenhua Shao, Lin Cheng, Yu Zhao, Jiangang Fan   +10 more
wiley   +1 more source

Escape Room Activity to Teach Head and Neck Anatomy. [PDF]

MedEdPORTAL
Holan G, Asri R, Yadav A, Traba C, Chen S, Grachan JJ.   +5 more
europepmc   +1 more source

Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition [PDF]

Homer et al.
core  

Neural Plasticity and Hearing‐Speech Development in Children with Auditory Brainstem Implants for Congenital Hearing Loss Due to Severe Inner Ear Malformation

Advanced Science, EarlyView.
Data from a prospective cohort with 112 auditory brainstem implant users are analyzed. Younger age at implantation (<3 years), less severe inner‐ear malformation (common cavity, cochlear aplasia, and hypoplasia), and more intraoperative eABR evoked electrodes (≥60%) are associated with better hearing and speech outcomes.
Yu Zhang, Yongchuan Chai, Yiwen Zhang, Huan Jia, Zhaoyan Wang, Zhihua Zhang, Zhili Wang, Jie Chen, Xue Wang, Yun Li, Ying Chen, Hao Wu   +11 more
wiley   +1 more source